TRIB
Trinity Biotech plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$9.50
−1.04%Leverage
- Debt / equity
- -1.92x
- Net debt / equity
- -1.85x
- Debt / assets
- 1.31x
- Debt / EBITDA
- -16.11x
- Net debt / EBITDA
- -15.51x
Liquidity & coverage
- Current ratio
- 0.25x
- Quick ratio
- 0.12x
- Cash ratio
- 0.04x
- Interest coverage
- -0.53x
- EBITDA / interest
- -0.40x
- Working capital
- -$105.3M
Cash & dividend
- FCF / debt
- -0.05x
- Cash flow / debt
- -0.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025